logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table PDU-6. Estimated trends in the prevalence of problem and injecting drug use, 2003 to 2008 (rate per 1 000 population aged 15 to 64): combined estimates per country [see all tables in this series...]

Part (i) Estimated trends of overall problem drug use

Country200320042005200620072008Drug use [1]Method [1]
Czech Republic4.024.144.374.134.24.39PDUTM
Denmark7.38:7.53::PDUCR
Germany2.52.72.652.091.752.14POUPM
Greece2.382.622.562.72.732.68PDUCR
Italy7.478.088.1::9.8PDUTM
Cyprus:1.911.341.53.662.00PDUTP
Malta:5.86.25.7:POUCR
Austria55.385.434.54.14POUCR
Slovakia::4.84.94.72.68PDUOT
United Kingdom9.2610.1510.199.97:PDUOT

Notes:

 Data represents a selection based on the availablity of the same estimation method over time. In some countries more estimates might be available. In other countries data are insufficient to report.  

 Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution. 

 The original age range for Malta in 2006 is 12 to 64 years old. 

 The original age range of studies for Finland was 15–54. 

 [1] - POU = Problem opioid use; PDU = Problem drug use. TM = Treatment Multiplier ; HM = HIV Multiplier ; MM = Mortality Multiplier ; MI = Multivariate Indicator Method ; PM = Police Multiplier ; TP = Truncated Poisson ; CM = Combined Methods. CR = Capture Recapture, OT = Other Methods. 

Related links:

 Statistical bulletin 2009: Table PDU-06 part i 

 For more details see Tables PDU-1, PDU-102 and PDU-103 in the Statistical bulletin 2010. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page 

 See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich (http://www.emcdda.eu.int/?nnodeid=1372). 

Sources:

 Reitox national focal points 

 2009 REITOX National Reports - Fonte PDU template 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 05 January 2011